Annual report
7747.TEDINET S100RWXB
Period2022-07-01 → 2023-06-30
Filed2023-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥90.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥61.5bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥56.5bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.2bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥18.0bn | 2022-07-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥15.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥17.6bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥13.2bn | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.3bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.8bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥17.7bn | 2022-07-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥15.7bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥13.1bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.0bn | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.2bn | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.2bn | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥13.3bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥172.6bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥155.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥115.4bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥93.7bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥84.4bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.3bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥34.0bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥134.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥121.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥92.9bn | at 2021-06-30d | Cons. | Net assets |
| Net assets / equity | ¥72.0bn | at 2020-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥65.5bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.6bn | at 2020-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥18.8bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥19.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥17.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.9bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.2bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥15.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥16.3bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.4bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥10.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥850m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥267m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥48.25 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.25 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.25 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.29 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.07 | 2020-07-01 → 2021-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.07 | 2019-07-01 → 2020-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2018-07-01 → 2019-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥487.12 | at 2023-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.8 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥349.18 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥276.13 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥251.37 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.6% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.4% | 2022-07-01 → 2023-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 10,187 | at 2023-06-30 | Cons. | Number of employees |
| Employees | 10,435 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 9,409 | at 2021-06-30d | Cons. | Number of employees |
| Employees | 8,761 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 7,810 | at 2019-06-30d | Cons. | Number of employees |
| Revenue | ¥63.7bn | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥63.5bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥50.9bn | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥47.4bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.1bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.3bn | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥12.3bn | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥13.2bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥8.9bn | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.0bn | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.9bn | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.1bn | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥12.8bn | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | ¥7.2bn | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥9.5bn | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥6.7bn | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.9bn | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.9bn | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥127.3bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥120.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥91.4bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.3bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥60.9bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥37.1bn | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥34.7bn | at 2022-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥90.2bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥86.2bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥67.2bn | at 2021-06-30d | Standalone | Net assets |
| Net assets / equity | ¥49.6bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥44.1bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥25.4bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥23.0bn | at 2022-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥26.61 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.09 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.8 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.32 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.51 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.68 | 2020-07-01 → 2021-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.16 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.32 | 2018-07-01 → 2019-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥14.48 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.99 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.26 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8.81 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21.61 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥332.15 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥317.39 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.48 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.43 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥169.61 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 70.9% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.3% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.5% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 271,633,600 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 271,633,600 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 265,972,800 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 260,561,600 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 130,134,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,016 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 1,041 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 925 | at 2021-06-30d | Standalone | Number of employees |
| Employees | 875 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 755 | at 2019-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥315m |
| Reconciling Itemsreconciling | depreciation | 2022-07-01 → 2023-06-30 | ¥295m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | ¥17.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-06-30 | −¥4.5bn |
| Devicereportable segment | capex | 2022-07-01 → 2023-06-30 | ¥6.3bn |
| Devicereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥2.9bn |
| Devicereportable segment | employees | at 2023-06-30 | 3425 pure |
| Devicereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥26.0bn |
| Devicereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥11.5bn |
| Devicereportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥14.5bn |
| Devicereportable segment | segment assets | at 2023-06-30 | ¥39.3bn |
| Devicereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥6.1bn |
| Medicalreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥7.8bn |
| Medicalreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥4.3bn |
| Medicalreportable segment | employees | at 2023-06-30 | 6188 pure |
| Medicalreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥78.6bn |
| Medicalreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥78.6bn |
| Medicalreportable segment | segment assets | at 2023-06-30 | ¥115.6bn |
| Medicalreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥16.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-07-01 → 2023-06-30 | ¥14.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-07-01 → 2023-06-30 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-06-30 | ¥104.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-06-30 | ¥90.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-06-30 | ¥154.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-06-30 | ¥22.5bn |
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥261m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥280m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥17.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥4.1bn |
| Devicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥3.0bn |
| Devicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Devicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥23.3bn |
| Devicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| Devicereportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Devicereportable segment | segment assets | at 2022-06-30 | ¥33.5bn |
| Devicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Medicalreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5.7bn |
| Medicalreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3.7bn |
| Medicalreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | segment assets | at 2022-06-30 | ¥104.5bn |
| Medicalreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥14.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥91.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥77.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥138.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥19.4bn |
| Devicereportable segment | employees | at 2023-06-30 | 293 pure |
| Medicalreportable segment | employees | at 2023-06-30 | 607 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,549
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 141 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 154 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 136 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 1.272 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 1.472 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.283 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.998 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.369 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.896 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.901 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.123 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.081 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.322 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 6188 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 96 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 3425 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 74 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 574 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 7 | |
| Number of employees | CurrentYearInstant | 10187 | |
| Average number of temporary workers | CurrentYearInstant | 177 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1016 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 136 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 36.7 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7.3 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6280945 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 607 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 74 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 293 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 59 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 116 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 3 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 1016 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 136 | |
| Research and development expenses research and development activities | CurrentYearDuration | 9723000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 8109000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 1613000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 14456000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 7841000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 6300000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 315000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 271633600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 271633600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 271633600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 271633600 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 51 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 38 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 149 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |